Abstract
Antiphospholipid Syndrome (APS) is a systemic autoimmune disease characterized by the persistent positivity of one or more antiphospholipid antibodies (aPL), that recognize phospholipid-binding proteins such as ¿2-glycoprotein I (¿2GPI). This binding triggers the activation of inflammatory and prothrombotic cells, significantly increasing the risk of thrombosis and obstetric complications…